# EDGAR Filing Document

**Accession Number:** 0001158780
**File Stem:** 0001213900-25-052382
**Filing Date:** 2025-6
**Character Count:** 9086
**Document Hash:** 233bcecbec9308d90e14cf4a009f81f0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-052382.hdr.sgml**: 20250609

**ACCESSION NUMBER**: 0001213900-25-052382

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250609

**DATE AS OF CHANGE**: 20250609

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Pluri Inc.
- **CENTRAL INDEX KEY:** 0001158780
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 980351734
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-78785
- **FILM NUMBER:** 251032995

**BUSINESS ADDRESS:**
- **STREET 1:** MATAM ADVANCED TECHNOLOGY PARK
- **STREET 2:** BUILDING NO. 5
- **CITY:** HAIFA
- **STATE:** L3
- **ZIP:** 3508409
- **BUSINESS PHONE:** 972-74-710-7171

**MAIL ADDRESS:**
- **STREET 1:** MATAM ADVANCED TECHNOLOGY PARK
- **STREET 2:** BUILDING NO. 5
- **CITY:** HAIFA
- **STATE:** L3
- **ZIP:** 3508409

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PLURISTEM THERAPEUTICS INC
- **DATE OF NAME CHANGE:** 20071228

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PLURISTEM LIFE SYSTEMS INC
- **DATE OF NAME CHANGE:** 20030701

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AI SOFTWARE INC
- **DATE OF NAME CHANGE:** 20010906
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Franco-Yehuda Chen
- **CENTRAL INDEX KEY:** 0001770681

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**MAIL ADDRESS:**
- **STREET 1:** MATAM ADVANCED TECHNOLOGY PARK
- **STREET 2:** BUILDING NO. 5
- **CITY:** HAIFA
- **STATE:** L3
- **ZIP:** 31905

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**Pluri Inc.**

*(Name of Issuer)*

**Common Shares, par value $0.00001 per share**

*(Title of Class of Securities)*

**72942G203**

*(CUSIP Number)*

**Chen Franco-Yehuda**<br>17 Gogen Street<br>Kiryat Ata L3 2826617<br>972535225922

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**04/27/2023**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **72942G203** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Chen Franco-Yehuda** | Name of reporting person<br>**Chen Franco-Yehuda** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**L3** | Citizenship or place of organization<br>**L3** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**40064.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**40064.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**40064.00** | Aggregate amount beneficially owned by each reporting person<br>**40064.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.51%** | Percent of class represented by amount in Row (11)<br>**0.51%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** (1) Based on a total of 7,875,555 common shares, par value $0.00001 per share (the "Common Shares") of Pluri Inc. (the "Issuer") outstanding as of June 4, 2025, as reported by the Issuer to Ms. Franco-Yehuda (the "Reporting Person").

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Shares, par value $0.00001 per share

**(b) Name of Issuer:**
Pluri Inc.

**(c) Address of Issuer's Principal Executive Offices:**
MATAM Advanced Technology Park, Building No. 5, Haifa, L3, 3508409

**Item 4. Purpose of Transaction**

"Item 4. Purpose of Transaction" is being amended and restated by this Amendment No. 1 as follows:

All of the Issuer's securities directly owned by the Reporting Person was acquired for investment purposes and in consideration for the Reporting Person's services as a former executive officer of the Issuer.

In pursuing these purposes, the Reporting Person may further purchase, hold, trade, dispose or otherwise deal in securities of the Issuer. Except as set forth in the previous paragraph, the Reporting Person has no current plans or proposals which relate to or would result in (a) an acquisition by any person of additional securities of the Issuer, or the disposition by any person of securities of the Issuer; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the Issuer or of any of its subsidiaries; (d) any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) any material change in the present capitalization or dividend policy of the Issuer; (f) any other material change in the Issuer's business or corporate structure; (g) changes in the Issuer's charter, bylaws or instruments corresponding thereto or other actions with may impede the acquisition of control of the Issuer by any person; (h) causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934, as amended; or (j) any action similar to any of those enumerated herein. The Reporting Person may, at any time and from time to time, review or reconsider her position and formulate plans or proposals with respect thereto.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The Reporting Person beneficially owns 40,064 Common Shares, representing approximately 0.51% of the outstanding Common Shares.

**(b)**
The Reporting Person is deemed to hold sole voting and dispositive power over 40,064 Common Shares of the Issuer.

**(c)**
Set forth below is a description of all transactions in the Issuer's securities effected by the Reporting Person during the past 60 days.

Date of Transaction        Number of Shares Sold      Price Per Share ($)          Where and How the
                                                                                                                        Transaction Was Effected
04/24/2025                                       3,282                               $5.85                         Open market
04/24/2025                                       3,500                               $6.80                         Open market
04/24/2025                                       5,000                               $5.23                         Open market

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

"Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer" is being amended and restated by this Amendment No. 1 as follows:

There are no present contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Person, and any other person with respect to the securities of the Issuer, including, but not limited to, transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangement, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Chen Franco-Yehuda

**Signature:** /s/ Chen Franco-Yehuda

**Name/Title:** Chen Franco-Yehuda

**Date:** 06/09/2025